A detailed history of Advisor Group Holdings, Inc. transactions in Nevro Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 784 shares of NVRO stock, worth $4,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
784
Previous 1,309 40.11%
Holding current value
$4,578
Previous $7,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 04, 2025

SELL
$5.84 - $5.84 $3,066 - $3,066
-525 Reduced 40.11%
784 $4,000
Q2 2025

Aug 13, 2025

BUY
$5.84 - $5.84 $4,228 - $4,228
724 Added 123.76%
1,309 $7,000
Q1 2025

May 12, 2025

BUY
$3.29 - $5.85 $1,069 - $1,901
325 Added 125.0%
585 $3,000
Q4 2024

Jun 06, 2025

BUY
$3.59 - $5.78 $1,884 - $3,034
525 Added 89.74%
1,110 $4,000
Q1 2024

May 10, 2024

SELL
$13.56 - $20.78 $185,026 - $283,543
-13,645 Reduced 98.13%
260 $3,000
Q4 2023

Feb 12, 2024

BUY
$14.18 - $22.31 $48,126 - $75,720
3,394 Added 32.29%
13,905 $299,000
Q3 2023

Nov 13, 2023

BUY
$18.22 - $25.85 $2,915 - $4,136
160 Added 1.55%
10,511 $202,000
Q2 2023

Aug 10, 2023

SELL
$22.62 - $39.32 $5,971 - $10,380
-264 Reduced 2.49%
10,351 $263,000
Q1 2023

May 12, 2023

BUY
$30.17 - $41.11 $3,982 - $5,426
132 Added 1.26%
10,615 $383,000
Q4 2022

Feb 10, 2023

BUY
$36.43 - $49.4 $115,155 - $156,153
3,161 Added 43.17%
10,483 $415,000
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $126,533 - $165,029
-3,112 Reduced 29.83%
7,322 $340,000
Q2 2022

Aug 10, 2022

BUY
$40.85 - $77.67 $145,507 - $276,660
3,562 Added 51.83%
10,434 $458,000
Q1 2022

May 04, 2022

BUY
$59.95 - $92.06 $100,356 - $154,108
1,674 Added 32.2%
6,872 $496,000
Q3 2021

Nov 05, 2021

SELL
$101.99 - $166.36 $63,029 - $102,810
-618 Reduced 10.63%
5,198 $604,000
Q2 2021

Aug 02, 2021

BUY
$141.6 - $179.06 $144,290 - $182,462
1,019 Added 21.24%
5,816 $964,000
Q1 2021

May 13, 2021

BUY
$132.81 - $182.18 $81,014 - $111,129
610 Added 14.57%
4,797 $669,000
Q4 2020

Feb 10, 2021

SELL
$138.17 - $184.34 $89,948 - $120,005
-651 Reduced 13.46%
4,187 $725,000
Q3 2020

Nov 12, 2020

BUY
$114.09 - $145.51 $97,889 - $124,847
858 Added 21.56%
4,838 $674,000
Q2 2020

Aug 14, 2020

BUY
$89.45 - $129.85 $87,034 - $126,344
973 Added 32.36%
3,980 $477,000
Q1 2020

May 18, 2020

BUY
$70.23 - $144.31 $211,181 - $433,940
3,007 New
3,007 $300,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $207M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.